Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

MedMira startet Klinische Tests mit Multiplo® Complete Syphilis (TP/nTP) Antibody Test - ein möglicher Game Changer um die Syphilis-Gesundheitskrise in Kanada zu meistern: https://www.irw-press.at/prcom/images/messages/2024/76536/MedMira_14082024_DEPRcom.001.png
MedMira startet Klinische Tests mit Multiplo® Complete Syphilis (TP/nTP) Antibody Test - ein möglicher Game Changer um die Syphilis-Gesundheitskrise in Kanada zu meistern

Halifax, Nova Scotia, 13. August 2024 - MedMira Inc. (MedMira) (TSXV: MIR) gibt mit Freude bekannt, dass es vollständige klinische Studien für seinen einzigartigen Multiplo® Complete

MicroVision meldet die Ergebnisse des zweiten Quartals 2024: https://www.irw-press.at/prcom/images/messages/2024/76468/MicroVisionNR08072024_DE_PRcom.003.png
MicroVision meldet die Ergebnisse des zweiten Quartals 2024

REDMOND, WA / ACCESSWIRE / 7. August 2024 / MicroVision, Inc. (NASDAQ:MVIS), ein führender Anbieter von MEMS-basierten Festkörper-Automobil-LiDAR- und modernen Fahrerassistenzlösungen (ADAS),

MicroVision Announces Second Quarter 2024 Results: https://www.irw-press.at/prcom/images/messages/2024/76468/MicroVisionNR08072024_PRcom.003.png
MicroVision Announces Second Quarter 2024 Results

REDMOND, WA / ACCESSWIRE / August 7, 2024 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS-based solid-state automotive lidar and ADAS solutions, today announced its second quarter 2024

Medical Technology Stock Benefits from Rising Acute Care Demand: https://www.marketbeat.com/logos/articles/med_20240804190513_chartg-syk.jpg
Medical Technology Stock Benefits from Rising Acute Care Demand

Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry. Acute care is considered short-term intensive

Humana Slides on Profitability Concerns Despite Q2 Earnings Beat: https://www.marketbeat.com/logos/articles/med_20240801073139_humana-slides-on-profitability-concerns-despite-q2.jpg
Humana Slides on Profitability Concerns Despite Q2 Earnings Beat

Humana Inc. (NYSE: HUM) is a leading health insurer predominantly focused on Medicare Advantage plans, serving millions of individuals and families nationwide. The company's business model centers

Is This Telehealth Stock a Buy After the Recent Pullback?: https://www.marketbeat.com/logos/articles/med_20240719104001_is-this-telehealth-stock-a-buy-after-the-recent-pu.jpg
Is This Telehealth Stock a Buy After the Recent Pullback?

Hims & Hers Health, Inc. (NYSE: HIMS) is a prominent player in the telehealth sector, which is part of the larger healthcare sector.  The company has garnered significant attention from

Why This Healthcare Stock is a Strong Buy Despite Headwinds: https://www.marketbeat.com/logos/articles/med_20240716075118_chart-unh-7162024ver001.png
Why This Healthcare Stock is a Strong Buy Despite Headwinds

UnitedHealth Group (NYSE: UNH) has headwinds, but its healthcare business and operational quality offset them, setting the stock to hit new all-time highs. The primary culprit is the recent

Strategic Buy Lights Up This Biotech Stock: Time to Invest?: https://www.marketbeat.com/logos/articles/med_20240715092117_chartm-ilmn.jpg
Strategic Buy Lights Up This Biotech Stock: Time to Invest?

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. This comes after its divestiture and spin-off of

Top 4 Must-Have Healthcare Stocks for Long-Term Growth: https://www.marketbeat.com/logos/articles/med_20240711100558_top-4-must-have-healthcare-stocks-for-long-term-gr.jpg
Top 4 Must-Have Healthcare Stocks for Long-Term Growth

The healthcare industry represents a substantial and dynamic market sector, presenting many opportunities for investors seeking long-term growth and stability. Factors such as the aging

This Tech Stock Can Set a Multiyear High with AI-Powered Growth: https://www.marketbeat.com/logos/articles/med_20240710082907_chart-sgh-7102024ver001.png
This Tech Stock Can Set a Multiyear High with AI-Powered Growth

SMART Global Holdings' (NASDAQ: SGH) repositioning efforts have set it up to achieve record-high share prices soon. The company’s Q3 results aren’t perfect, but include critical details that

Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market

Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound. Mounjaro is prescribed for Type 2 diabetes but is

HealthEquity Stock: Leading Health Savings Account Investment
HealthEquity Stock: Leading Health Savings Account Investment

HealthEquity Inc (NASDAQ: HQY) is one of the nation’s largest providers of health savings accounts (HSA) and consumer-directed benefits (CDB) services. Its platform enables individuals to open

Centene Reaffirms Guidance, But Is it Too Late?
Centene Reaffirms Guidance, But Is it Too Late?

Managed care health insurance company Centene Inc. (NYSE: CNC) recently saw its share rebound after reaffirming its guidance. This move came just after UnitedHealth Group Inc. (NYSE: UNH) made

Is Cigna Group the Nation's Best-Run Health Insurance Company?
Is Cigna Group the Nation's Best-Run Health Insurance Company?

Health insurance companies in the medical sector have not fared well in 2024. Medicare Advantage (MA) plans were a bountiful source of income until the second half of 2023. Humana Inc. (NYSE: HUM)

Medtronic Dips: Is Now the Time to Buy?
Medtronic Dips: Is Now the Time to Buy?

Shares of Medtronic (NYSE: MDT) are falling following its FQ4 release and guidance, opening up a potential buying opportunity. The question is whether its value, yield, balance sheet and cash flow

2 Stocks Providing Medical Insurance for Your Pets
2 Stocks Providing Medical Insurance for Your Pets

The pandemic triggered a surge in pet ownership as social distancing and lockdowns resulted in the need for companionship for many individuals and families. Anyone who owns a dog or cat can

CVS Health Stock Has a Silver Lining Called Value
CVS Health Stock Has a Silver Lining Called Value

Integrated healthcare retailer and insurer CVS Health Co. (NYSE: CVS) stock presents a value not seen in years. The medical sector giant saw its shares punished on its Q1 2024 top and bottom line

Undervalued UnitedHealth Group Won’t Be For Long
Undervalued UnitedHealth Group Won’t Be For Long

UnitedHealth Group's (NYSE: UNH) Q1 results were better than expected for two reasons: First, the stock price is now rebounding from long-term lows and deep value territory with ample upside

Novo Nordisk Arms Wegovy to Be a Triple Threat
Novo Nordisk Arms Wegovy to Be a Triple Threat

Ozempic usage for weight loss has gone viral, making it the highest revenue-generating drug for Novo Nordisk AV/S (NYSE: NVO). Originally purposed for Type 2 diabetes, the skyrocketing off-label

DexCom Stock Gains from GLP-1 Diabetic Users
DexCom Stock Gains from GLP-1 Diabetic Users

DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People with diabetes use CGM systems to

MedMira erhält kanadisches Patent für sein einzigartiges quantitatives Diagnosesystem
MedMira erhält kanadisches Patent für sein einzigartiges quantitatives Diagnosesystem

Halifax, Nova Scotia, 13. März 2024 - Heute gibt MedMira Inc. (MedMira) (TSXV: MIR) den Erhalt eines kanadischen Patents (Nummer 2.949.634) für sein neues innovatives und quantitatives

MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System

Halifax, Nova Scotia, March 13, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a Canadian patent (number 2,949,634) for its new innovative and quantitative test

Medtronic is a Dividend Aristocrat That Keeps Gaining
Medtronic is a Dividend Aristocrat That Keeps Gaining

Medical device maker Medtronic PLC (NYSE: MDT) is a Dividend Aristocrat in the medical and healthcare sectors. The medical device maker has raised its dividend payout for 46 consecutive years

Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?
Is UnitedHealth Group Stock a Strong Buy or a Falling Knife?

UnitedHealth Group Inc. (NYSE: UNH) has given up almost all of its 12-month gains in the last week after two unrelated incidents have rocked the company. At the close of trading on March 1, 2024

Can UnitedHealth Group afford to keep Medicare Advantage plans?
Can UnitedHealth Group afford to keep Medicare Advantage plans?

Medicare Advantage plans have been making headlines in 2024, but not in a positive light, at least for health insurance companies. Medicare is a government-sponsored health insurance benefit